Tuesday, 20 Mar 2018

You are here

The RheumNow Week in Review - 16 February 2018

Dr. Jack Cush reviews highlights, news and recent research published this week on RheumNow.com. This week's report includes news on social media, new rituximab indications, steroid complications, DECT in Gout, T2T in gout, Dementia and rheumatology numbers.

  1. Cambridge study shows that hand thermoregulation is more dependant on muscle mass and not fat - this may be why more women than men bothered by "cold hands" https://t.co/j5zCt3ntW8
  2. Pharmacovigilance using Twitter? A UK study compared glucocorticoid AE on Twitter vs UK MHRA regulatory system; in 3 yrs, Twitter Identified 20,210 Steroid AE, but only 3022 via MHRA. Twitter AE “common but not serious”, most being insomnia and weight gain https://buff.ly/2o8LW9F
  3. FDA grants priority review for Genentechs Rituxan for use in pemphigus vulgaris https://t.co/e6uKQOf55f
  4. 240,000 Canadian COPD patients, >55 yrs; those on inhaled corticosteroids (>4 yrs, >1gm) had 10% higher rate of fractures (men and women) https://t.co/N4rJwrfohY
  5. Systematic review of DECT Scanning in Gout included 32 articles & 1502 pts. DECT takes little time and has low radiation exposure but limited availability. It showed Sensitivity & Specificity > 80%. Dx performance was better than Xray, CT, equal to US https://t.co/GkbSKNP7D2   
  6. Although epratuzumab (anti-CD22 MAb) failed in SLE in two phase III clinical trials, subanalyses show that pts w/ secondary Sjogrens who were SSA positive (7.1% of 1584 enrolled) where more likely to have a BICLA response and decreases in B cells and IgM. https://t.co/n6Woy8rTka
  7. T2T Improves Primary Care Gout Management  
  8. DMARDs Lower Dementia Risk in Rheumatoid Arthritis  40% reduction; 50% w/ MTX 
  9. NHANES Survey Shows OA Rising and RA Declining 


The author has received compensation as an advisor or consultant on this subject

Add new comment

More Like This

MMWR: Arthritis Prevalence Increases and Varies Widely

MMWR reports that In 2015, the number of adults with arthritis continued to increase; with marked geographic variability in arthritis estimates with gaps in arthritis management.

The CDC estimates that physician-diagnosed arthritis affects 54 million of adults in the United States with an annual cost of approximately $300 billion annually.

The RheumNow Week in Review - 16 March 2018

Dr. Jack Cush reviews the highlights from the news, journals and major meetings. Bigtime rheumatologic lessons with tales from intestinal crypts, the friendly skies & the hips of hockey players. Also the microbiome and lupus, benefits of ENT findings with GPA and rare risk of opportunistic infections with biologics.

The RheumNow Week in Review - 9 March 2018

Dr. Jack Cush reviews highlights, news and recent research published this past week on RheumNow.com. This week's report includes news on new regulatory changes, new indication for tofacitinib, the rise and deficits of opioids and the benefits of fish and bariatric surgery.

ACR Responds to Association Health Plans Proposed Rule

In comments submitted today to the US Department of Labor in response to its Association Health Plans (AHP) proposed rule, the American College of Rheumatology urged Administration officials to protect essential health benefits and other consumer protections that make it possible for individuals living with rheumatic diseases to access comprehensive and affordable healthcare.

The RheumNow Week in Review - 2 March 2018

Dr. Jack Cush reviews the news and highlights from the past week on RheumNow.com.